Enhancing Prognostication in Hepatocellular Carcinoma Treated With Transarterial Chemoembolization: Beyond Baseline ALBI Grade
Journal of Gastroenterology and Hepatology · 2026-05 · 41 (5) · 1627-1628
DOI: 10.1111/jgh.70355 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of Gastroenterology and Hepatology, online erschienen am 22.03.2026. Verfasst von Talha Khan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Riphah International University Islamic International Medical College, Islamabad, Pakistan. Die Arbeit nennt 6 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Riphah International University Islamic International Medical College, Islamabad, Pakistan.
- Ziauddin University, Karachi, Pakistan.
- Corewell Health William Beaumont University Hospital, Royal Oak, Michigan, USA.
ORCID-Profile: Talha Khan, Ali Raamiz Rizvi, Reja Ahmad, Hasnain Wajeeh Saqib
Zitieren
APA
Khan, T., Rizvi, A. R., Ahmad, R., Saqib, H. W., & Moazzam, M. (2026). Enhancing Prognostication in Hepatocellular Carcinoma Treated With Transarterial Chemoembolization: Beyond Baseline ALBI Grade. Journal of Gastroenterology and Hepatology, 41(5), 1627-1628. https://doi.org/10.1111/jgh.70355
Vancouver
Khan T, Rizvi AR, Ahmad R, Saqib HW, Moazzam M. Enhancing Prognostication in Hepatocellular Carcinoma Treated With Transarterial Chemoembolization: Beyond Baseline ALBI Grade. Journal of Gastroenterology and Hepatology. 2026;41(5):1627-1628. doi:10.1111/jgh.70355
BibTeX
@article{Khan2026,
author = {Khan, Talha and Rizvi, Ali Raamiz and Ahmad, Reja and Saqib, Hasnain Wajeeh and Moazzam, Mujtaba},
title = {Enhancing Prognostication in Hepatocellular Carcinoma Treated With Transarterial Chemoembolization: Beyond Baseline ALBI Grade},
journal = {Journal of Gastroenterology and Hepatology},
year = {2026},
volume = {41},
number = {5},
pages = {1627--1628},
doi = {10.1111/jgh.70355}
}
EUVIMED